SXI Life Sciences
6.905,90
PKT
+48,39
PKT
+0,71
%
Werbung
Analysen zu SXI Life Sciences-Werten
Datum | Rating | Analyst | |
---|---|---|---|
17.07.06 | Novartis kaufen | Independent Research | |
18.07.06 | Novartis halten | National-Bank AG | |
17.07.06 | Novartis buy | SEB | |
14.07.06 | Novartis kaufen | Fuchsbriefe | |
17.07.06 | Novartis overweight | Prudential Financial | |
13.07.06 | Novartis buy | Merrill Lynch | |
13.07.06 | Novartis neutral-weight | Prudential Financial | |
10.07.06 | Novartis kaufen | Euro am Sonntag | |
07.07.06 | Novartis | Weberbank | |
05.07.06 | Sonova kaufen | Bank Hofmann | |
26.06.06 | Novartis | Wirtschaftswoche | |
16.06.06 | Novartis buy | SEB | |
20.06.06 | Novartis buy | Jyske Bank | |
15.06.06 | Sonova | Focus Money | |
14.06.06 | Novartis outperform | Goldman Sachs | |
14.06.06 | Novartis overweight | Morgan Stanley | |
13.06.06 | Novartis buy | Jyske Bank | |
09.06.06 | Novartis kaufen | Weberbank | |
07.06.06 | Novartis | Jyske Bank | |
19.05.06 | Novartis outperform | Goldman Sachs | |
23.05.06 | Novartis buy | Jyske Bank | |
18.05.06 | Novartis buy | Merrill Lynch | |
17.05.06 | Novartis buy | Merrill Lynch | |
15.05.06 | Basilea Pharmaceutica | Global Biotech Investing | |
18.05.06 | Novartis buy | Jyske Bank | |
12.05.06 | Novartis outperform | Goldman Sachs | |
11.05.06 | Novartis | Zürcher Kantonalbank | |
11.05.06 | Novartis buy | Merrill Lynch | |
10.05.06 | Novartis buy | A.G. Edwards & Sons | |
02.05.06 | Novartis Buy | Rochdale Securities | |
03.05.06 | Novartis buy | Jyske Bank | |
26.04.06 | Novartis peer perform | Bear Stearns | |
26.04.06 | Novartis kaufen | Aktienservice Research | |
27.04.06 | Novartis neutral | JP Morgan | |
26.04.06 | Novartis overweight | Prudential Financial | |
25.04.06 | Novartis kaufen | Frankfurter Tagesdienst | |
25.04.06 | Novartis buy | Merrill Lynch | |
26.04.06 | Novartis overweight | Lehman Brothers | |
26.04.06 | Novartis outperform | Goldman Sachs | |
26.04.06 | Novartis overweight | Prudential Financial |